- Home
- WW vs PLRX Comparison
WW vs PLRX Comparison
Compare WW & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WW
- PLRX
- Stock Information
- Founded
- WW 1961
- PLRX 2015
- Country
- WW United States
- PLRX United States
- Employees
- WW N/A
- PLRX N/A
- Industry
- WW Other Consumer Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- WW Consumer Discretionary
- PLRX Health Care
- Exchange
- WW Nasdaq
- PLRX Nasdaq
- Market Cap
- WW 75.9M
- PLRX 90.9M
- IPO Year
- WW 2001
- PLRX 2020
- Fundamental
- Price
- WW $0.45
- PLRX $1.46
- Analyst Decision
- WW Hold
- PLRX Hold
- Analyst Count
- WW 3
- PLRX 10
- Target Price
- WW $2.58
- PLRX $9.79
- AVG Volume (30 Days)
- WW 74.2M
- PLRX 744.6K
- Earning Date
- WW 05-06-2025
- PLRX 05-20-2025
- Dividend Yield
- WW N/A
- PLRX N/A
- EPS Growth
- WW N/A
- PLRX N/A
- EPS
- WW N/A
- PLRX N/A
- Revenue
- WW $765,944,000.00
- PLRX N/A
- Revenue This Year
- WW N/A
- PLRX N/A
- Revenue Next Year
- WW N/A
- PLRX N/A
- P/E Ratio
- WW N/A
- PLRX N/A
- Revenue Growth
- WW N/A
- PLRX N/A
- 52 Week Low
- WW $0.12
- PLRX $1.10
- 52 Week High
- WW $2.33
- PLRX $16.52
- Technical
- Relative Strength Index (RSI)
- WW 48.84
- PLRX 41.55
- Support Level
- WW $0.38
- PLRX $1.43
- Resistance Level
- WW $0.86
- PLRX $1.72
- Average True Range (ATR)
- WW 0.15
- PLRX 0.11
- MACD
- WW 0.03
- PLRX 0.05
- Stochastic Oscillator
- WW 33.02
- PLRX 27.78
About WW WW International Inc.
WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.